Original Article
Modern Pathology (2008) 21, 950–960; doi:10.1038/modpathol.2008.71; published online 23 May 2008
Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer
Ruth L Katz1, Tanweer M Zaidi1, Ricardo L Fernandez1, Jingpin Zhang1, Weigong He1, Charisse Acosta1, Michal Daniely2, Lea Madi2, Mary A Vargas3, Qiong Dong3, Xiaoying Gao Feng Jiang4, Nancy P Caraway1, Ara A Vaporciyan5, Jack A Roth5 and Margaret R Spitz3
- 1Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 2Bioview Ltd, Rehovoth, Israel
- 3Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 4Department of Pathology, University of Maryland, Baltimore, MD, USA
- 5Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Correspondence: Dr RL Katz, Department of Pathology, Unit 53, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. E-mail: rkatz@mdanderson.org
Received 27 November 2007; Revised 21 March 2008; Accepted 24 March 2008; Published online 23 May 2008.
Abstract
Detection of lung cancer by sputum cytology has low sensitivity but is noninvasive and, if improved, could be a powerful tool for early lung cancer detection. To evaluate whether the accuracy of diagnosing lung cancer by evaluating sputa for cytologic atypia and genetic abnormalities is greater than that of conventional cytology alone, automated scoring of genetic abnormalities for 3p22.1 and 10q22.3 (SP-A) by fluorescence in situ hybridization (FISH) and conventional cytology was done on sputa from 35 subjects with lung cancer, 25 high-risk smokers, and 6 healthy control subjects. Multivariate analysis was performed to select variables that most accurately predicted lung cancer. A model of probability for the presence of lung cancer was derived for each subject. Cells exfoliated from patients with lung cancer contained genetic aberrations and cytologic atypias at significantly higher levels than in those from control subjects. When combined with cytologic atypia, a model of risk for lung cancer was derived that had 74% sensitivity and 82% specificity to predict the presence of lung cancer, whereas conventional cytology achieved only 37% sensitivity and 87% specificity. For diagnosing lung cancer in sputum, a combination of molecular and cytologic variables was superior to using conventional cytology alone.
Keywords:
surfactant protein A gene, 3p22.1, FISH, cytology, field cancerization effect, sputum
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Gene-promoter hypermethylation as a biomarker in lung cancer
Nature Reviews Cancer Review (01 Sep 2004)
RESEARCH
Phylogenetic Differences among the Gm Factors of Non-human Primates
Nature Letters to Editor (21 Oct 1967)
British Journal of Cancer Original Article
EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens
Modern Pathology Original Article

